Aurobindo, Sun Pharma recall products in US market
According to the latest enforcement report issued by the US Food and Drug Administration (USFDA), the US-based arm of Aurobindo Pharma is recalling 1,15,776 bottles of Moxifloxacin Ophthalmic Solution, an antibiotic used in the treatment of bacterial infections.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Avelox | Biotechnology | Food and Drug Administration (FDA) | Moxifloxacin | Opthalmology | Pharmaceuticals